©2026 Hevantra. All Rights Reserved | Designed by SlashMonk
Thought Leadership
Thought Leadership
THOUGHT LEADERSHIP
Our commitment to advancing the field is demonstrated through peer-reviewed research and international conference presentations. Below is a selection of our team’s contributions.
1. Bisen R, Thakur L, Puthran D (2025)
The Impact of Network Meta-Analyses on HTA Decisions in Oncology: A Review of NICE Appraisals. ISPOR Europe, 9-12 November 2025, Glasgow, Scotland.
2. Bisen R, Thakur L , Puthran D (2025)
Evaluating Therapeutic Landscape in Radioiodine-refractory Differentiated Thyroid Cancer (DTC): A Bayesian Network Meta-analysis of Clinical Efficacy. ISPOR Europe, 9-12 November 2025, Glasgow, Scotland.
3. Thakur L, Bisen R, Puthran D (2025)
Budget Impact analysis of GLP-1 Receptor Agonists for Type 2 Diabetes Management in India. ISPOR Europe, 9-12 November 2025, Glasgow, Scotland.
4. Thakur L, Bisen R, Sharma A (2024)
Budget Analysis of Lenvatinib and Sorafenib as First-Line Treatments for Radioiodine-Refractory Differentiated Thyroid Cancer in the United States. ISPOR US, 13-16 May 2024, Montreal, Quebec, Canada.
5. Bisen R, Thakur L, Shivsingwale G (2024)
Evaluating therapeutics landscape in differentiated thyroid cancer (DTC): A systematic review of clinical efficacy and safety. Systematic Literature Review and Meta-Analysis, 2024.
6. Bisen R, Thakur L, Shivsingwale G, Gunde D, Mukta Y (2024)
A Systematic Review of Pharmacological Interventions for Hidradenitis Suppurativa: A Focus on Clinical Response, Quality of Life, and Safety. ISPOR Europe, 17-20 November 2024, Barcelona, Spain.
7. Bisen R, Thakur L, Shivsingwale G, Gunde D, Mukta Y (2024)
Insight from Randomized Controlled Trials on the Efficacy and Safety of Pharmacological Therapies for Differentiated Thyroid Cancer: A Systematic Review. ISPOR Europe, 17-20 November 2024, Barcelona, Spain.
8. Bisen R, Thakur L, Bisen V, Shivsingwale G (2023)
Burden of Chronic Lymphocytic Leukemia in the United States: A Review of Literature. ISPOR Europe, 12-15 November 2023, Copenhagen, Denmark.
9. Bisen R, Thakur L, Shivsingwale G, Mukta Y, Gunde D (2023)
Economic Evaluations of Pharmacological Interventions for Lupus Population – a Targeted Literature Review. ISPOR Europe, 12-15 November 2023, Copenhagen, Denmark.
10. Bisen R, Thakur L, Shivsingwale G, Gunde D, Mukta Y (2023)
A Targeted Literature Review of Cost-Utility Analyses for Ulcerative Colitis/Crohn’s Disease Treatment. ISPOR Europe, 12-15 November 2023, Copenhagen, Denmark.
11. Proudfoot C, Gautam R, 2, Cristino J, Agrawal R, Thakur L, Tolley K (2022)
Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure. The European Journal of Health Economics, 2022
12. Shaddy R, George A, Jaecklin T, Nic Lochlainn E, Thakur L, Agrawal R, Solar-Yohay S, Chen F, Rossano J, Severin T, Burch M (2019)
Systematic literature review on the incidence and prevalence of heart failure in children and adolescents. Pediatric Cardiology, 2019
13. Burch M, Nallagangula T, Nic Lochlainn E, Severin T, Thakur L, Jaecklin T, George A, Solar-Yohay S, Rossano J, Shaddy R (2019)
Systematic literature review on the economic, humanistic, and societal burden of heart failure in children and adolescents. Expert Review of Pharmacoeconomics & Outcomes Research, 2019
14. Kuemmerle-Deschner J, Thakur L, George A, Hur P (2019)
A systematic review of the effectiveness and safety of pharmacological treatments in systemic idiopathic juvenile arthritis (SJIA). EULAR Congress, Madrid, 2019
15. Kaushik N, ,Bisen R Bhutani MK, Taneja A (2018)
Economic burden of Fragile X Syndrome in Europe and the US: A systematic literature review. ISPOR Europe, 10-14 Nov 2018, Barcelona, Spain.
16. Sharma N, Bisen R, Rawat NS, Afaque A, Gupta S (2018)
Economic burden of Myasthenia Gravis in the US: A literature review. ISPOR US, 19-23 May 2018, Baltimore, MD, USA.
17. Ahuja A, Agrawal R, Thakur L, Natani H, Cristino J, Croft D, Gielen V (2017)
Randomized controlled trials in heart failure with preserved ejection fraction (HFpEF) – A systematic review of patient populations. ISPOR Europe, 5-9 November 2017, Glasgow, Scotland.
18. Agrawal R, Ahuja A, Thakur L, Natani H, Cristino J, Croft D, Gielen V (2017)
A systematic review on the efficacy of pharmacological treatments in heart failure with preserved ejection fraction (HFpEF). ISPOR Europe, 5-9 November 2017, Glasgow, Scotland.
19. Srivastava K, Rajora P, Gupta S, Bisen R (2015)
Evidence review group (ERG) critique of Systematic reviews (SR) submitted to nice as Part of single technology appraisals (STA) or multiple technology appraisals (MTA) in the last three years. ISPOR Europe, 7-11 November 2015, Milan, Italy.